Myomo to Report Third Quarter Financial Results on November 6, 2024
Myomo, a wearable medical robotics company focused on neurological disorders and upper-limb paralysis, has announced it will release its third quarter 2024 financial results on November 6, 2024. The company will host a conference call at 4:30 p.m. ET featuring remarks from chairman and CEO Paul R. Gudonis and CFO David Henry. Participants can pre-register for the call or dial in directly. A webcast will be available on Myomo's Investor Relations page, with replay access until November 20, 2024.
Myomo, una società di robotics medica indossabile focalizzata sui disturbi neurologici e sulla paralisi degli arti superiori, ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre del 2024 il 6 novembre 2024. L’azienda ospiterà una conferenza telefonica alle 16:30 ET con interventi del presidente e CEO Paul R. Gudonis e del CFO David Henry. I partecipanti possono pre-registrarsi per il convegno o chiamare direttamente. Sarà disponibile un webcast nella pagina delle Relazioni con gli Investitori di Myomo, con accesso alla registrazione fino al 20 novembre 2024.
Myomo, una empresa de robótica médica portátil centrada en trastornos neurológicos y parálisis de extremidades superiores, ha anunciado que lanzará sus resultados financieros del tercer trimestre de 2024 el 6 de noviembre de 2024. La compañía organizará una llamada de conferencia a las 4:30 p.m. ET con comentarios del presidente y CEO Paul R. Gudonis y del CFO David Henry. Los participantes pueden preinscribirse para la llamada o llamar directamente. Habrá una transmisión web disponible en la página de Relaciones con Inversores de Myomo, con acceso a la repetición hasta el 20 de noviembre de 2024.
Myomo, 신경 장애 및 상지 마비에 중점을 둔 착용 가능한 의료 로봇 회사가 2024년 3분기 재무 결과를 2024년 11월 6일 발표할 것이라고 발표했습니다. 회사는 오후 4시 30분(ET)에 회의 전화를 주최하며, 회장 겸 CEO인 Paul R. Gudonis와 CFO인 David Henry가 발언합니다. 참가자는 전화를 사전 등록하거나 직접 전화할 수 있습니다. Myomo의 투자자 관계 페이지에서 웹캐스트를 시청할 수 있으며, 2024년 11월 20일까지 재청취할 수 있습니다.
Myomo, une entreprise de robotique médicale portable axée sur les troubles neurologiques et la paralysie des membres supérieurs, a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le 6 novembre 2024. La société organisera une conférence téléphonique à 16 h 30 HE avec des commentaires du président et PDG Paul R. Gudonis et du CFO David Henry. Les participants peuvent s'inscrire à l'avance pour la conférence ou appeler directement. Un webinaire sera disponible sur la page des Relations Investisseurs de Myomo, avec un accès à la rediffusion jusqu'au 20 novembre 2024.
Myomo, ein Unternehmen für tragbare medizinische Robotik, das sich auf neurologische Störungen und Lähmungen der oberen Gliedmaßen konzentriert, hat angekündigt, dass es am 6. November 2024 seine Finanzergebnisse des dritten Quartals 2024 veröffentlichen wird. Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz abhalten, in der der Vorsitzende und CEO Paul R. Gudonis sowie CFO David Henry sprechen werden. Teilnehmer können sich im Voraus für den Anruf registrieren oder direkt anrufen. Ein Webcast wird auf der Investor-Relations-Seite von Myomo verfügbar sein, mit Zugang zur Wiederholung bis zum 20. November 2024.
- None.
- None.
The Company will host a conference call the same day, Wednesday November 6, 2024 at 4:30 p.m. ET with prepared remarks by Paul R. Gudonis, chairman and chief executive officer, and David Henry, chief financial officer.
Participants are encouraged to pre-register for the conference call using this link. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register may dial in by calling, 1-844-707-6932 (
A replay of the webcast will be available beginning approximately one hour after the completion of the live conference call at https://ir.myomo.com/. A dial-in replay of the call will be available until November 20, 2024; please dial 1-877-344-7529 (
About Myomo, Inc.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the
View source version on businesswire.com: https://www.businesswire.com/news/home/20241030078888/en/
For Myomo:
ir@myomo.com
Investor Relations:
Kim Sutton Golodetz
Alliance Advisors IR
kgolodtez@allianceadvisors.com
212-838-3777
Source: Myomo, Inc.
FAQ
When will Myomo (MYO) report Q3 2024 earnings?
What time is Myomo's (MYO) Q3 2024 earnings call?
How long will Myomo's (MYO) Q3 2024 earnings call replay be available?